📌 Key Takeaways
- Topic: Is There a Quartz Sand Shortage? Causes, Impact and Supply Outlook
- Keywords: silica clarifying agent
- Published: 2026-11-20 00:29:53
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Grace Syloid: Silica Product Range for Coatings, Pharma and Food
- Silica as a Moisture Absorber: How It Works and How Much You Need
- 94. Lyytikäinen J., Kyllönen S., Ervasti T., Komulainen E., Pekarek T., Slunečková J., Leskinen J., Ketolainen J., Kubelka T., Stasiak P., et al. Challenges encountered in the transfer of atorvastatin tablet manufacturing - Commercial batch-based production as a basis for small-scale continuous tablet manufacturing tests. Int. J. Pharm. 2023;647:123509. doi: 10.1016/j.ijpharm.2023.123509. [ DOI ] [ PubMed ] [ Google Scholar ]
- Nouryon Levasil: Colloidal Silica Product Range and Applications
- What Is the Common Name for Silicon Dioxide? Silica, Quartz and Other Names
- Silica Manufacturer in India: Key Producers, Product Ranges and Export Capabilities
- This equation fits especially well for premature release, up to 60% of the drug released, when there is no change in the matrix system during the release process. From a perspective of pore geometry, it basically controls drug release rates by affecting effective diffusion pathways. Boosted complexity of geometries raises tortuosity and reduces effective diffusion. High tortuosity and low pore connectivity cut down drug diffusion, consequently lowering the release rates. Furthermore, surface roughness and pore size distribution affect surface region, diffusion, and residence times, and thereby drug release kinetics. Thus, coupling the Fick diffusion model with parameters characterizing pore geometry (e.g., porosity, tortuosity, etc.) enables for more precise and automatic modeling of drug release kinetics. In this way, it is nicely clarified why release profiles differ for chemically comparable matrices due to differences in their geometrical shapes [ 59, 60 ].
What Is Hollow Silica? Structure, Properties and Applications
What is silica (SiO₂)?
foundry silica sand
What is the difference between fumed silica and precipitated silica?
hydrophobic fumed silica
What drives silica raw material prices?
toothpaste grade silica MSNs are SiO 2 nanoparticles [ 2 ] with a pore diameter between 2 and 50 nm [ 3, 4 ] and with a total diameter of a maximum of 1 µm. Their use in drug delivery dates to the early 1990s when they were synthesized for various scientific applications [ 5 ]. The material known as mesoporous silica was discovered by Mobil Oil Corporation in 1992 [ 6 ]. Their first drug delivery application was demonstrated in 2001 when MCM-41 silica was used to release ibuprofen [ 7 ]. Since then, MSNs have become an increasingly popular drug delivery system due to their advantageous properties and have been typically recognized as secure (GRAS) by the FDA. Tiny SNPs have been approved for human clinical imaging studies, setting the stage for their use in clinical applications of drug delivery. The number of related research activities is continuously increasing each year, expanding their role in cancer treatment, gene delivery, and oral illness therapy [ 5 ]. Their pore size is located between microporous and macroporous systems. They can be used in diverse shapes (sphere, cube, ellipsoid, rod) and sizes, with different pore sizes and pore structures [ 2, 3, 4, 8, 9, 10 ]. They have a high degree of stability [ 8 ] and a rigid framework, which results in resistance to temperature, pH, enzymatic degradation, and mechanical force [ 4 ]. Thanks to the large number of pores, they have a massive particular surface region (approx. 700-1300 m 2 /g) and pore volume (approx. 0.5-1.5 cm 3 /g), which enables effective adsorption of diverse molecules [ 2, 3, 4, 8, 9, 10 ]. By changing the pore size distribution, the range of adsorbable molecules can be controlled [ 3 ], which also lets separation based on size exclusion, which means selective adsorption of molecules of certain sizes. Depending on the size of the pores, tiny molecules together with high molecular weight proteins can be transported into the pores [ 8 ]. In addition, chemical separation is also possible if the surface of the pores is coated with specific functional groups [ 4 ], which enables the separation of the APIs according to their structure [ 4 ]. Such modifications may include the setting of hydrophilicity/hydrophobicity of the surface, depending on whether the adsorption of hydrophobic or hydrophilic molecules is targeted [ 4 ]. By inserting different functional groups, the surface charge can also be controlled so that certain molecules will bind more efficiently. MSNs have a negative surface charge in biological environments, which promotes the electrostatic adsorption of positively charged APIs in the pores [ 10 ]. Moreover, the biological markers attached to the surface of the nanoparticles enable the drug-carrying system to deliver the API in a tissue-specific manner [ 2, 4, 8, 9, 10 ]. A substantial problem is the premature release of the API from the pores during transport [ 4, 8 ], which can be solved by utilizing gatekeepers that respond to special stimuli and keep the pores closed until the stimulus [ 2, 4, 8 ]. In this way, controlled drug delivery and stimuli-responsive release can be achieved [ 2, 4, 9 ]. The drug release could be triggered by temperature, pH, redox potential, light, enzymes, magnetic field, or different ligands [ 4, 8, 11 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.